Citations

Mayo Clinic

Showing 10 of 108602 citations.

Pediatric Epicardial Devices: Early and Midterm Outcomes
Griffeth, Elaine M. , Krishnan, Prasad , Dearani, Joseph A. , Ackerman, Michael J. , Wackel, Philip L. , Cannon, Bryan C. , Dearani, Joseph A. , Pahwa, Siddharth , Todd, Austin W.

World Journal for Pediatric and Congenital Heart Surgery | March 5, 2023 | Volume: 14 | Issue: 4 | Pages: 451-458

10.1177/21501351231157374 | PMID 36851830 Get It

Background Lead performance is suboptimal in young patients and a main cause of device system failure. Our objective was to assess early and midterm outcomes after epicardial device implantation in a contemporary pediatric cohort. Methods A total of 116 consecutive pediatric patients underwent 137 epicardial device implantations from 2010 to 2019. Forty pacemakers and 97 implantable cardioverter defibrillators (ICDs) were implanted. Lead failure was defined as leads repaired, replaced, or abandoned due to fracture, dislodgement, or dysfunction. Freedom from device system failure was determined using Kaplan-Meier analysis. Results Mean age at implantation was 10 ± 5 years, 46 (34%) were younger than 8 years old, 41 (30%) had prior cardiac surgery, and 38 (28%) had prior devices. Main indications were acquired heart block (17/40 [43%]), sinus node dysfunction (14/40 [35%]), and congenital heart block (7/40 [18%]) for pacemakers, and hypertrophic cardiomyopathy (46/97 [47%]), long QT syndrome (31/97 [32%]), and ventricular arrhythmia (17/97 [18%]) for ICDs. There were no early deaths. Three-year freedom from device system failure was 80% (95% CI 73%, 88%) for all patients and 88% (95% CI 79%, 99%) for patients <8 years old. Device system failure causes included lead fracture (20/34 [59%]), lead dysfunction (5/34 [15%]), lead dislodgement (5/34 [15%]), infection (3/34 [9%]), and pericarditis (1/34 [3%]). Reintervention was required in 26/34 (76%) device system failures. Conclusions Epicardial device implantation is safe, shows acceptable midterm outcomes in children, and is an effective option in patients younger than 8 years old. Close device surveillance continues to be essential to detect lead failure early and ensure timely reintervention.
Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition
Parkman, Henry P. , Murray, Helen Burton , Yates, Katherine P. , Grover, Madhusudan , Malik, Zubair , Schey, Ron , Bulat, Robert, Koch, Kenneth L. , Sarosiek, Irene , Shulman, Robert J. , Farrugia, Gianrico , Miriel, Laura , Tonascia, James , Hamilton, Frank A., Pasricha, Pankaj J. , McCallum, Richard W. , Abell, T L , Parkman, H P , Burton-Murray, Helen , Blackford, Amanda , Kuo, Braden , Chumpitazi, Bruno P. , Abell, Thomas L.

Journal of Parenteral and Enteral Nutrition | March 4, 2023 | Volume: 47 | Issue: 4 | Pages: 541-549

10.1002/jpen.2493 | PMID 36871132 Get It

AbstractBackgroundPatients with gastroparesis (Gp) may need enteral nutrition (EN) or exclusive parenteral nutrition (PN). Among patients with Gp, we aimed to (1) identify the frequency of EN and exclusive PN use and (2) explore characteristics of patients using EN and/or exclusive PN compared with those using oral nutrition (ON), including changes over 48 weeks.MethodsPatients with Gp underwent history and physical examination, gastric emptying scintigraphy, water load satiety testing (WLST), and questionnaires assessing gastrointestinal symptoms and quality of life (QOL). Patients were observed 48 weeks.ResultsOf 971 patients with Gp (idiopathic, 579; diabetic, 336; post–Nissen fundoplication, 51), 939 (96.7%) were using ON only, 14 (1.4%) using exclusive PN, and 18 (1.9%) using EN. Compared with patients receiving ON, patients receiving exclusive PN and/or EN were younger, had lower body mass index, and had greater symptom severity. Patients receiving exclusive PN and/or EN had lower physical QOL but not mental QOL or Gp‐related QOL scores. Patients receiving exclusive PN and/or EN ingested less water during WLST but did not have worse gastric emptying. Of those who had been receiving exclusive PN and/or EN, 50% and 25%, respectively, resumed ON at 48‐week follow‐up.ConclusionsThis study describes patients with Gp requiring exclusive PN and/or EN for nutrition support, who represent a small (3.3%) but important subset of patients with Gp. Unique clinical and physiological parameters are associated with this subset and provide insight into the use of nutrition support in Gp.
Variability in Lipid Levels and Risk for Cardiovascular Disease: An Electronic Health Record–Based Population Cohort Study
Manemann, Sheila M., Moser, Ethan D. , Roger, Véronique L. , Chamberlain, Alanna M. , Remaley, Alan T. , Decker, Paul A. , Killian, Jill M. , Larson, Nicholas B. , Bielinski, Suzette , Moser, Ethan D , Takahashi, Paul Y. , Roger, Veronique L , Chamberlain, Alanna M , Killian, Jill M , Larson, Nicholas B , Bielinski, Suzette J. , Sauver, Jennifer L. St. , Olson, Janet E. , Decker, Paul A.

Journal of the American Heart Association | March 4, 2023 | Volume: 12 | Issue: 5 | Pages: No page available

10.1161/jaha.122.027639 | PMID 36870945 Get It

Background Larger within‐patient variability of lipid levels has been associated with increased risk of cardiovascular disease (CVD); however, measures of lipid variability require ≥3 measurements and are not currently used clinically. We investigated the feasibility of calculating lipid variability within a large electronic health record–based population cohort and assessed associations with incident CVD. Methods and Results We identified all individuals ≥40 years of age who resided in Olmsted County, MN, on January 1, 2006 (index date), without prior CVD, defined as myocardial infarction, coronary artery bypass graft surgery, percutaneous coronary intervention, or CVD death. Patients with ≥3 measurements of total cholesterol, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol, or triglycerides during the 5 years before the index date were retained. Lipid variability was calculated using variability independent of the mean. Patients were followed through December 31, 2020 for incident CVD. We identified 19 652 individuals (mean age 61 years; 55% female), who were CVD‐free and had variability independent of the mean calculated for at least 1 lipid type. After adjustment, those with highest total cholesterol variability had a 20% increased risk of CVD (Q5 versus Q1 hazard ratio, 1.20 [95% CI, 1.06–1.37]). Results were similar for low‐density lipoprotein cholesterol and high‐density lipoprotein cholesterol. Conclusions In a large electronic health record–based population cohort, high variability in total cholesterol, high‐density lipoprotein cholesterol, and low‐density lipoprotein cholesterol was associated with an increased risk of CVD, independent of traditional risk factors, suggesting it may be a possible risk marker and target for intervention. Lipid variability can be calculated in the electronic health record environment, but more research is needed to determine its clinical utility.
CHARACTERISTICS AND PREDICTORS OF PATIENTS WITH SEPSIS WHO ARE CANDIDATES FOR MINIMALLY INVASIVE APPROACH OUTSIDE OF INTENSIVE CARE UNIT
Smith, Ryan J. , Lal, Amos , Malinchoc, Michael, Gajic, Ognjen, Lal, Amos , Wahab, Abdul, Flurin, Laure , Dong, Yue , Gajic, Ognjen

Shock | March 4, 2023 | Volume: 59 | Issue: 5 | Pages: 702-707

10.1097/shk.0000000000002112 | PMID 36870069 Get It

ABSTRACT Objective: To identify and describe characteristics of patients with sepsis who could be treated with minimally invasive sepsis (MIS) approach without intensive care unit (ICU) admission and to develop a prediction model to select candidates for MIS approach. Methods: A secondary analysis of the electronic database of patients with sepsis at Mayo Clinic, Rochester, MN. Candidates for the MIS approach were adults with septic shock and less than 48 hours of ICU stay, who did not require advanced respiratory support and were alive at hospital discharge. Comparison group consisted of septic shock patients with an ICU stay of more than 48 hours without advanced respiratory support at the time of ICU admission. Results: Of 1795 medical ICU admissions, 106 patients (6%) met MIS approach criteria. Predictive variables (age >65 years, oxygen flow >4 L/min, temperature <37°C, creatinine >1.6 mg/dL, lactate >3 mmol/L, white blood cells >15 × 109/L, heart rate >100 beats/min, and respiration rate >25 breaths/min) selected through logistic regression were translated into an 8-point score. Model discrimination yielded the area under the receiver operating characteristic curve of 79% and was well fitted (Hosmer-Lemeshow P = 0.94) and calibrated. The MIS score cutoff of 3 resulted in a model odds ratio of 0.15 (95% confidence interval, 0.08–0.28) and a negative predictive value of 91% (95% confidence interval, 88.69–92.92). Conclusions: This study identifies a subset of low-risk septic shock patients who can potentially be managed outside the ICU. Once validated in an independent, prospective sample our prediction model can be used to identify candidates for MIS approach.
Molecular Breast Imaging in the Screening Setting
Smith, Katherine Allen, Hunt, Katie N. , Fowler, Amy M. , Smith, Katherine A, Fowler, Amy M , Smith, Katherine A, Rauch, Gaiane M.

Journal of Breast Imaging | March 4, 2023 | Volume: 5 | Issue: 3 | Pages: 240-247

10.1093/jbi/wbad011 | PMID 38416886 Get It

Abstract Early detection of breast cancer through screening mammography saves lives. However, the sensitivity of mammography for breast cancer detection is reduced in women with dense breast tissue. Imaging modalities for supplemental breast cancer screening include MRI, whole breast US, contrast-enhanced mammography, and molecular breast imaging (MBI). Molecular breast imaging with 99mTc-sestamibi is a functional imaging test to identify metabolically active areas in the breast with positioning analogous to mammography. Since 2011, there have been six large, published studies of screening MBI as a supplement to mammography involving over 6000 women from four different institutions. A multicenter, prospective clinical trial of 3000 women comparing breast cancer detection using screening digital breast tomosynthesis alone or in combination with MBI recently completed enrollment. This review focuses on the current evidence of MBI use for supplemental breast cancer screening, the strengths and limitations of MBI, and recent technological advances.
Personalized risk communication and opioid prescribing in association with nonprescribed opioid use: A secondary analysis of a randomized controlled trial
Tiako, Max Jordan Nguemeni , Shofer, Frances S. , Dolan, Abby , Goldberg, Erica , Rhodes, Karin V. , Bellamkonda, Venkatesh R. , Perrone, Jeanmarie , Cannuscio, Carolyn C. , Rodgers, Melissa A. , Zyla, Michael M , Bell, Jeffrey J , McCollum, Sharon, Schapira, Marilyn M. , Nguemeni Tiako, Max Jordan , Engel-Rebitzer, Eden , Hess, Erik P. , Perrone, Jeanmarie , Becker, Lance B. , Engel‐Rebitzer, Eden , Meisel, Zachary F.

Academic Emergency Medicine | March 4, 2023 | Volume: 30 | Issue: 8 | Pages: 851-858

10.1111/acem.14710 | PMID 36869633 Get It

AbstractBackgroundTo determine the impact of personalized risk communication and opioid prescribing on nonprescribed opioid use, we conducted a secondary analysis of randomized controlled trial participants followed prospectively for 90 days after an emergency department (ED) visit for acute back or kidney stone pain.MethodsA total of 1301 individuals were randomized during an encounter at four academic EDs into a probabilistic risk tool (PRT) arm, a narrative‐enhanced PRT arm, or a general risk information arm (control). In this secondary analysis, both risk tool arms were combined and compared with the control arm. We used logistic regressions to determine associations between receiving personalized risk information, receiving an opioid prescription in the ED, and nonprescribed opioid use in general and by race.ResultsComplete follow‐up data were available for 851 participants; 23.3% (n = 198) were prescribed opioids (34.2% of White vs. 11.6% of Black participants, p < 0.001). Fifty‐six (6.6%) participants used nonprescribed opioids. Participants in the personalized risk communication arms had lower nonprescribed opioid use odds (adjusted odds ratio [aOR] 0.58, 95% confidence interval [CI] 0.4–0.83). Black versus White participants had greater nonprescribed opioid use odds (aOR 3.47, 95% CI 2.05–5.87, p < 0.001). Black participants who were prescribed opioids had a lower marginal probability of using nonprescribed opioids versus those who were not (0.06, 95% CI 0.04–0.08, p < 0.001 vs. 0.10, 95% CI 0.08–0.11, p < 0.001). The absolute risk difference in nonprescribed opioid use for Black and White participants, respectively, in the risk communication versus the control arm, was 9.7% and 0.1% (relative risk ratio 0.43 vs. 0.95).ConclusionsAmong Black but not White participants, personalized opioid risk communication and opioid prescribing were associated with lower odds of nonprescribed opioid use. Our findings suggest that racial disparities in opioid prescribing—which have been previously described within the context of this trial—may paradoxically increase nonprescribed opioid use. Personalized risk communication may effectively reduce nonprescribed opioid use, and future research should be designed specifically to explore this possibility in a larger cohort.
Reply
Abdelmalek, Manal F. , Covic, Lidija , Kuliopulos, Athan , Abdelmalek, Manal

Hepatology | March 4, 2023 | Volume: 77 | Issue: 5 | Pages: E111-E112

10.1097/hep.0000000000000285 | PMID 36869845 Get It

Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech
Robinson, Carling G. , Utianski, Rene L. , Singh, Neha Atulkumar , Pham, Nha Trang Thu, Ertekin‐Taner, Nilüfer , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Clark, Heather A, Utianski, Rene L , Singh, Neha Atulkumar , Whitwell, Jennifer , Josephs, Keith A , Duffy, Joseph R. , Clark, Heather A., Machulda, Mary M. , Botha, Hugo , Dickson, Dennis W.

European Journal of Neurology | March 4, 2023 | Volume: 30 | Issue: 5 | Pages: 1209-1219

10.1111/ene.15764 | PMID 36869612 Get It

AbstractObjectivePrimary progressive apraxia of speech (PPAOS) is associated with imaging abnormalities in the lateral premotor cortex (LPC) and supplementary motor area (SMA). It is not known whether greater involvement of these regions in either hemisphere is associated with demographics, presenting, and/or longitudinal features.MethodsIn 51 prospectively recruited PPAOS patients who completed [18F]‐fluorodeoxyglucose (FDG) positron emission tomography (PET), we classified patients as left‐dominant, right‐dominant, or symmetric, based on visual assessment of the LPC and SMA on FDG‐PET. SPM and statistical analyses of regional metabolic values were performed. Diagnosis of PPAOS was made if apraxia of speech was present and aphasia absent. Thirteen patients completed ioflupane‐123I (dopamine transporter [DAT]) scans. We compared cross‐sectional and longitudinal clinicopathological, genetic, and neuroimaging characteristics across the three groups, with area under the receiver‐operating curve (AUROC) determined as a measure of effect size.ResultsIn all, 49% of the PPAOS patients were classified as left‐dominant, 31% as right‐dominant, and 20% as symmetric, which was supported by results from the SPM and regional analyses. There were no differences in baseline characteristics. Longitudinally, right‐dominant PPAOS showed faster rates of progression of ideomotor apraxia (AUROC 0.79), behavioral disturbances (AUROC 0.84), including disinhibition symptoms (AUROC 0.82) and negative behaviors (AUROC 0.82), and parkinsonism (AUROC 0.75) compared to left‐dominant PPAOS. Symmetric PPAOS showed faster rates of dysarthria progression compared to left‐dominant (AUROC 0.89) and right‐dominant PPAOS (AUROC 0.79). Five patients showed abnormal DAT uptake. Braak neurofibrillary tangle stage differed across groups (p = 0.01).ConclusionsPatients with PPAOS and a right‐dominant pattern of hypometabolism on FDG‐PET have the fastest rates of decline of behavioral and motor features.
Towards Pattern Recognition with Network Science and Natural Language Processing for Information Retrieval
Garg, Muskan , Kumar, Mukesh , Samanta, Debabrata

Proceedings of the 12th International Conference on Pattern Recognition Applications and Methods | March 4, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.5220/0011779700003411 Get It